EUPRAXIA PHARMACEUTICALS INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 20, 2025
Use the contents to explore the available documents and sections.
EPRX$6.89+4.4%Stored close · as of Nov 6, 2026
Contents
EX-99.3 · Use of Proceeds
Use of Proceeds
The following table shows the estimated use of net proceeds from the Offering, compared with the actual use of net proceeds:
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.